- Novartis AG
- Pharmacia Corp.
- Gen-Probe Inc.
- Abbott Laboratories Inc.
- Bayer AG
- Organon Teknika BV
- Akzo Nobel NV
- Genentech Inc.
- Ortho Diagnostic Systems Inc.
- Johnson & Johnson
- PathoGenesis Corp.
- Berlex Laboratories Inc.
- Schering AG
- Eli Lilly & Co.
- Schering-Plough Corp.
- Idec Pharmaceuticals Corp.
- ImClone Systems Inc.
- Corixa Corp.
- Coulter Pharmaceutical Inc.
- Immunex Corp.
- Takeda Oncology
- CuraGen Corp.
- Genaissance Pharmaceuticals Inc.
- Chiron and Gen-Probe ally to develop blood screening products
- Chiron, Roche settle diagnostic patent litigation
- Ciba-Geigy and Sandoz merged in $27 billion deal
- Bausch & Lomb acquires Chiron's vision unit for $300mm
- Chiron buys rest of Hoechst AG's interest in Chiron Behring
- Bayer AG acquires Chiron Diagnostics for $1.1bn in cash
- Chiron acquires PathoGenesis for $729mm
- Cetus merges into Chiron creating major force in biotech.
- Chiron and Searle collaborate on coagulation inhibitor
- Chiron gets DepoTech's DepoCyt cancer therapeutic
- Genentech licenses Idec B-cell lymphoma treatment
- Chiron and Pathogenesis in drug discovery deal
- Corixa acquires Coulter for $882mm in stock swap
- Cell Genesys acquires Chiron's gene therapy facilities
- MitoKor acquires Chiron Corp.'s Chiron Technologies
Ask The Analyst
Ask the Analyst is free for subscribers. Submit your question and one of our analysts will be in touch.
Your question has been successfully sent to the email address below and we will get back as soon as possible. email@example.com.
All fields are required.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.